Home › Neuroendocrine Carcinoma › Texas › Houston
Neuroendocrine Carcinoma clinical trials in Houston, TX
6 studies for Neuroendocrine Carcinoma are looking for participants at sites in and around Houston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors
RecruitingPhase 1
- MD Anderson Cancer Center, Houston
- NEXT Houston, Houston
A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)
RecruitingPhase 1
- MD Anderson Cancer Center, Houston
A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors
RecruitingPhase 1/2
- Crinetics Study Site, Houston
A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer
RecruitingPhase 1/2
- The University of Texas MD Anderson Cancer Center, Houston
- Oncology Consultants, PA- Houston, Houston
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
RecruitingPhase 1/2
- MD Anderson Cancer Center, Houston
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
RecruitingPhase 1/2
- The University of Texas MD Anderson Cancer Center, Houston
Neuroendocrine Carcinoma trials in other cities
- New York City, NY6 studies
- Arlington, VA5 studies
- Dallas, TX4 studies
- Los Angeles, CA4 studies
- Washington, DC3 studies
- Seattle, WA3 studies
- Grand Rapids, MI3 studies
- Denver, CO3 studies
- Nashville, TN3 studies
- St. Louis, MO3 studies
- Atlanta, GA3 studies
- New Haven, CT3 studies
Other studies in Houston
- Non-Small Cell Lung Cancer145 studies
- Breast Cancer126 studies
- Cancer (all types)122 studies
- Metastatic Cancer104 studies
- Colorectal Cancer103 studies
- Ovarian Cancer90 studies
- Acute Myeloid Leukemia86 studies
- Lung Cancer78 studies
- Prostate Cancer76 studies
- Endometrial Cancer69 studies
- Pancreatic Cancer62 studies
- Melanoma59 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.